Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow
Clinical trial NCT00824538 · TERMINATED
Trial details
- NCT number
- NCT00824538
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-11-10
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.